[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Klein et al., 1982 - Google Patents

Detection and follow‐up of carcinoma of the urinary bladder by flow cytometry

Klein et al., 1982

View PDF
Document ID
11178945492233868866
Author
Klein F
Herr H
Sogani P
Whitmore Jr W
Melamed M
Publication year
Publication venue
Cancer

External Links

Snippet

Automated flow cytometry (FCM) has been used to study saline bladder irrigation specimens from nearly 400 patients at Memorial Sloan‐Kettering Cancer Center during the two‐year period March 1979–March 1981. These include 36 patients with papilloma, 35 with …
Continue reading at acsjournals.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/574Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407Specifically defined cancers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Electro-optical investigation, e.g. flow cytometers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material

Similar Documents

Publication Publication Date Title
Klein et al. Detection and follow‐up of carcinoma of the urinary bladder by flow cytometry
Klein et al. An evaluation of automated flow cytometry (FCM) in detection of carcinoma in situ of the urinary bladder
Badalament et al. The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma
Maier et al. The clinical value of urinary cytology: 12 years of experience with 615 patients.
Badalament et al. The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma
Blomjous et al. The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma
White et al. The predictive value of flow cytometric information in the clinical management of stage O (Ta) bladder cancer
Parry et al. Cancer detection by quantitative fluorescence image analysis
Bard The significance of asymptomatic microhematuria in women and its economic implications: a ten-year study
Renshaw et al. Cytology of grade 1 papillary transitional cell carcinoma
Farsund et al. Relation between flow cytometric DNA distribution and pathology in human bladder cancer. A report on 69 cases
Badalament et al. Monitoring intravesical bacillus Calmette‐Guerin treatment of superficial bladder carcinoma by serial flow cytometry
Klein et al. Flow cytometry of normal and nonneoplastic diseases of the bladder: An estimate of the false positive rate
Giella et al. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder
Melamed Flow cytometry of the urinary bladder
CA2429526A1 (en) Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
Klein et al. Flow cytometry followup of patients with low stage bladder tumors
Moran et al. Prognostic value of nucleolar organizer regions and ploidy values in advanced colorectal cancer
Klein et al. Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience
Bretton et al. Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin
Slaton et al. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder
Highman Transitional carcinoma of the upper urinary tract: a histological and cytopathological study.
Kern et al. Cytologic evaluation of transitional cell carcinoma of the bladder
Hermansen et al. Flow cytometry and cytology as response indicators to M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin)
Hermansen et al. Voided urine flow cytometry in screening high-risk patients for the presence of bladder cancer